Tilray Target of Unusually Large Options Trading (NASDAQ:TLRY)

Tilray Inc (NASDAQ:TLRY - Get Free Report) was the recipient of some unusual options trading activity on Wednesday. Investors purchased 75,369 call options on the company. This represents an increase of approximately 53% compared to the typical volume of 49,231 call options.

Insider Activity at Tilray

In other news, CFO Carl A. Merton acquired 26,000 shares of the company's stock in a transaction dated Friday, November 15th. The shares were bought at an average price of $1.36 per share, with a total value of $35,360.00. Following the purchase, the chief financial officer now owns 26,000 shares of the company's stock, valued at approximately $35,360. This represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.87% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the stock. Ferguson Wellman Capital Management Inc. bought a new position in shares of Tilray in the third quarter worth about $26,000. Verdence Capital Advisors LLC acquired a new position in Tilray in the fourth quarter worth about $29,000. Ameritas Advisory Services LLC acquired a new position in shares of Tilray in the 4th quarter worth approximately $32,000. Newman Dignan & Sheerar Inc. lifted its holdings in shares of Tilray by 61.9% during the fourth quarter. Newman Dignan & Sheerar Inc. now owns 26,150 shares of the company's stock valued at $35,000 after acquiring an additional 10,000 shares during the period. Finally, International Assets Investment Management LLC lifted its holdings in Tilray by 335.3% during the 3rd quarter. International Assets Investment Management LLC now owns 23,639 shares of the company's stock valued at $42,000 after purchasing an additional 18,208 shares during the last quarter. 9.35% of the stock is owned by institutional investors.

Tilray Stock Down 5.7 %

NASDAQ TLRY traded down $0.06 during trading on Friday, reaching $1.00. 66,104,744 shares of the company's stock were exchanged, compared to its average volume of 44,451,032. The company has a current ratio of 2.54, a quick ratio of 1.58 and a debt-to-equity ratio of 0.10. Tilray has a fifty-two week low of $0.97 and a fifty-two week high of $2.97. The company's fifty day simple moving average is $1.24 and its 200-day simple moving average is $1.52. The firm has a market capitalization of $937.66 million, a PE ratio of -3.33 and a beta of 2.07.

Tilray (NASDAQ:TLRY - Get Free Report) last posted its quarterly earnings results on Friday, January 10th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.07). The company had revenue of $210.90 million for the quarter, compared to analyst estimates of $216.34 million. Tilray had a negative return on equity of 4.40% and a negative net margin of 30.95%. The business's quarterly revenue was up 8.7% compared to the same quarter last year. Sell-side analysts predict that Tilray will post -0.2 EPS for the current year.

Analyst Ratings Changes

Separately, Canaccord Genuity Group lifted their target price on shares of Tilray from $2.00 to $3.00 and gave the stock a "buy" rating in a research report on Monday, January 13th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $2.70.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.